N

NYBC Ventures portfolio

NYBC Ventures has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is City Therapeutics's $99.5M Series B+ round in June 2026, alongside Viking Global Investors, Sofinnova Investments, Slate Path Capital and 6 others. By category, its portfolio leans toward Health and bio (3) and Logistics and mobility (1). It has co-invested with Sofinnova Investments, Viking Global Investors and Qatar Investment Authority, most often Sofinnova Investments (3 rounds).

What NYBC Ventures invests in

• Health and bio · 3 · 100%
• Logistics and mobility · 1 · 33%

NYBC Ventures recent investments

Company	Round	Date	Alongside
CCity Therapeutics	Series B+ · $99.5M	Jun 8, 2026	Viking Global Investors (lead), Sofinnova Investments (lead), Slate Path Capital +6
SStar Therapeutics	Series B+ · $125M	Oct 1, 2025	Westlake Village BioPartners, Viking Global Investors (lead), Soleus Capital +6
AAvenCell	Series B+ · $112M	Oct 22, 2024	Piper Heartland Healthcare Capital, Novo Holdings (lead), F-Prime Capital +2
SStar Therapeutics	Series B+ · $90M	Sep 5, 2023	Westlake Village BioPartners, Soleus Capital, Sofinnova Investments (lead) +6

How NYBC Ventures invests

Share is of the 4 rounds on Recent Funding that name NYBC Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

NYBC Ventures portfolio companies

• CCity Therapeutics$99.5MSeries B+ · Jun 2026
• SStar Therapeutics$125MSeries B+ · Oct 2025
• AAvenCell$112MSeries B+ · Oct 2024

Company	Round with NYBC Ventures	Total raised	Latest raise
CCity Therapeutics Health and bio	Jun 8, 2026 Series B+ · $99.5M	$234.5M	Jun 8, 2026 Series B+
SStar Therapeutics Health and bio	Oct 1, 2025 Series B+ · $125M	$215M	Oct 1, 2025 Series B+
AAvenCell Health and bio	Oct 22, 2024 Series B+ · $112M	$112M	Oct 22, 2024 Series B+

Most frequent co-investors

• SSofinnova Investments3 shared rounds · last Jun 8, 2026
• VViking Global Investors2 shared rounds · last Jun 8, 2026
• QQatar Investment Authority2 shared rounds · last Oct 1, 2025
• RRA Capital Management2 shared rounds · last Oct 1, 2025
• OOrbiMed2 shared rounds · last Oct 1, 2025
• SSoleus Capital2 shared rounds · last Oct 1, 2025
• RRedmile Group2 shared rounds · last Oct 1, 2025
• WWestlake Village BioPartners2 shared rounds · last Oct 1, 2025
• RRegeneron Ventures1 shared round · last Jun 8, 2026
• FFidelity1 shared round · last Jun 8, 2026
• AARCH Venture Partners1 shared round · last Jun 8, 2026
• IInvus1 shared round · last Jun 8, 2026

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• GGoHub Ventures3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo
• KKerna Ventures3 companies · 2 deals in 12 mo
• KKorea Credit Guarantee Fund3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists NYBC Ventures, which is a subset of its real portfolio. API: /api/v1/investors/nybc-ventures (get a free API key). More: the most active VC firms and new venture capital funds.